CY1112794T1 - Διαλυμα περιτοναϊκης αιμοκαθαρσης που περιεχει καρνιτινη το οποιο εχει βελτιωμενη βιοσυμβατοτητα - Google Patents

Διαλυμα περιτοναϊκης αιμοκαθαρσης που περιεχει καρνιτινη το οποιο εχει βελτιωμενη βιοσυμβατοτητα

Info

Publication number
CY1112794T1
CY1112794T1 CY20121100325T CY121100325T CY1112794T1 CY 1112794 T1 CY1112794 T1 CY 1112794T1 CY 20121100325 T CY20121100325 T CY 20121100325T CY 121100325 T CY121100325 T CY 121100325T CY 1112794 T1 CY1112794 T1 CY 1112794T1
Authority
CY
Cyprus
Prior art keywords
solution
bioscompatibility
improved
carnitine
peritoneal dialysis
Prior art date
Application number
CY20121100325T
Other languages
Greek (el)
English (en)
Inventor
Arduino Arduini
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of CY1112794T1 publication Critical patent/CY1112794T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
CY20121100325T 2005-03-10 2012-03-30 Διαλυμα περιτοναϊκης αιμοκαθαρσης που περιεχει καρνιτινη το οποιο εχει βελτιωμενη βιοσυμβατοτητα CY1112794T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2005000130 2005-03-10
EP06708437A EP1858504B1 (en) 2005-03-10 2006-02-22 Carnitine-containing peritoneal dialysis solution having improved biocompatibility

Publications (1)

Publication Number Publication Date
CY1112794T1 true CY1112794T1 (el) 2016-02-10

Family

ID=35159907

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100325T CY1112794T1 (el) 2005-03-10 2012-03-30 Διαλυμα περιτοναϊκης αιμοκαθαρσης που περιεχει καρνιτινη το οποιο εχει βελτιωμενη βιοσυμβατοτητα

Country Status (19)

Country Link
US (1) US20080138443A1 (https=)
EP (1) EP1858504B1 (https=)
JP (2) JP4717110B2 (https=)
KR (1) KR101324920B1 (https=)
AR (1) AR054015A1 (https=)
AT (1) ATE539742T1 (https=)
CA (1) CA2599252C (https=)
CY (1) CY1112794T1 (https=)
DK (1) DK1858504T3 (https=)
ES (1) ES2380168T3 (https=)
HR (1) HRP20120177T1 (https=)
ME (1) ME02948B (https=)
MX (1) MX2007010814A (https=)
PL (1) PL1858504T3 (https=)
PT (1) PT1858504E (https=)
RS (1) RS52237B (https=)
SI (1) SI1858504T1 (https=)
TW (1) TWI388318B (https=)
WO (1) WO2006094900A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365429B1 (es) * 2010-03-05 2012-09-06 Universidad De Castilla De La Mancha Solucion para dialisis peritoneal
WO2018031922A1 (en) * 2016-08-11 2018-02-15 Sulfilatec, Inc. Medical and nutritional compositions and methods of use
ES2750642A1 (es) * 2018-09-26 2020-03-26 Univ Vigo Composición farmacéutica que comprende proteína amiloide P de suero para tratar la insuficiencia renal aguda o crónica
EP3912656A1 (en) 2020-05-19 2021-11-24 CoreQuest Sagl Peritoneal dialysis solution

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126373A (en) 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
JPH08131542A (ja) * 1994-11-11 1996-05-28 Baxter Kk 腹膜透析液調製用溶液セット
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
GB9714218D0 (en) * 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
JP2001513370A (ja) * 1997-08-07 2001-09-04 グプタ，アジャイ 水溶性ビタミン及び栄養素を含む透析溶液
DE19748290B8 (de) 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
ATE336243T1 (de) * 1999-10-11 2006-09-15 Sigma Tau Ind Farmaceuti Verwendung von l-carnitin und seinen alkanoyl- derivaten als osmotisches mittel in lösungen für medizinische verwendung
JP2002282354A (ja) 2001-03-27 2002-10-02 Jms Co Ltd 腹膜透析液
GB0108359D0 (en) * 2001-04-03 2001-05-23 Allied Therapeutics Ltd Peritoneal dialysis fluid
ITRM20010337A1 (it) * 2001-06-14 2002-12-16 Sigma Tau Ind Farmaceuti Soluzione per la conservazione e perfuzione di organi in attesa che vengano trapiantati.
FR2840612B1 (fr) * 2002-06-06 2005-05-06 Roquette Freres Polymeres solubles de glucose hautement branches et leur procede d'obtention
JP2004016615A (ja) * 2002-06-19 2004-01-22 Fuso Pharmaceutical Industries Ltd 晶質浸透圧剤及び膠質浸透圧剤を含有する腹膜透析液
WO2004052269A1 (en) 2002-12-10 2004-06-24 Gambro Lundia Ab A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
JP2006075195A (ja) * 2004-09-07 2006-03-23 Jms Co Ltd Ｌカルニチン含有腹膜透析液

Also Published As

Publication number Publication date
HRP20120177T1 (hr) 2012-03-31
JP4717110B2 (ja) 2011-07-06
JP5366894B2 (ja) 2013-12-11
EP1858504A1 (en) 2007-11-28
RS52237B (sr) 2012-10-31
JP2008532601A (ja) 2008-08-21
ES2380168T3 (es) 2012-05-09
ME02948B (me) 2012-10-31
US20080138443A1 (en) 2008-06-12
PT1858504E (pt) 2012-04-10
SI1858504T1 (sl) 2012-04-30
KR101324920B1 (ko) 2013-11-01
AR054015A1 (es) 2007-05-30
ATE539742T1 (de) 2012-01-15
WO2006094900A1 (en) 2006-09-14
MX2007010814A (es) 2007-11-07
CA2599252C (en) 2013-07-30
JP2010207630A (ja) 2010-09-24
EP1858504B1 (en) 2012-01-04
DK1858504T3 (da) 2012-04-30
CA2599252A1 (en) 2006-09-14
TW200714279A (en) 2007-04-16
PL1858504T3 (pl) 2012-05-31
KR20070116630A (ko) 2007-12-10
TWI388318B (zh) 2013-03-11

Similar Documents

Publication Publication Date Title
BR0013648A (pt) Formulação farmacêutica contendo derivado de benzamida tendo solubilidade e absortividade oral melhoradas
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
BR0016555A (pt) Composições farmacêuticas que proporcionam concentrações acrescidas de droga
CY1109719T1 (el) Σκευασμα 1-[(3-υδροξυ-αδαμαντ-1-υλαμινο)-ακετυλο]-πυρρολιδινο-2-(s)-καρβονιτριλιου τροποποιημενης απελευθερωσης
BRPI0307786B8 (pt) composição farmacêutica, método para preparar a mesma, métodos para inibir a taxa de precipitação do agente da solução no trato gi, e para reduzir variabilidade inter-pacientes no que se refere à biodisponibilidade e/ou concentrações plásmáticas do agente, e, uso de um celulose éter solúvel em água ou de um éster de um celulose éter solúvel em água
CY1106203T1 (el) Η χρηση της l-καρνιτινης και των αλκανοϋλο παραγωγων αυτης σαν ωσμωτικων παραγοντων σε διαλυματα για ιατρικη χρηση
CY1112794T1 (el) Διαλυμα περιτοναϊκης αιμοκαθαρσης που περιεχει καρνιτινη το οποιο εχει βελτιωμενη βιοσυμβατοτητα
TW200602065A (en) Bicarbonate-based peritoneal dialysis solutions
CY1110664T1 (el) Ενδορινικες συνθεσετς
NO20022201L (no) Lösninger inneholdende Epinastin
BRPI0413957A (pt) processo para preparar diterpenos solúveis em água, solução aquosa e suas aplicações
TW200716202A (en) Pediatric formulation of topiramate
AR117718A2 (es) Mejoramientos en composiciones farmacéuticas, y relacionados con ellas
ATE274913T1 (de) Wässerige zusammensetzung enthaltend amphotericin b
ITMI20020189A1 (it) Composizione per uso farmaceutico o dietetico per contrastare la caduta dei capelli
BR0308316A (pt) Sais de nateglinida
PT2777689E (pt) Nova composição farmacêutica para o tratamento de infeções fúngicas
TN2010000008A1 (en) Oral pharmaceutical solutions containing telbivudine
FI3644967T3 (fi) Stabiili vesipitoinen hydroksikarbamidiliuos
BRPI0606119B8 (pt) preparações injetáveis de diclofenaco e seus sais farmaceuticamente aceitáveis
BR0214487A (pt) Composição farmacêutica que compreende uma combinação de metformina e um ácido 4-oxobutanóico, e o uso da mesma para o tratamento de diabetes
ES2168084B1 (es) Combinacion de aminas y compuestos de vanadio (iv) (v) para el tratatamiento y/o la prevencion de la diabetes mellitus.
CA2534259A1 (en) Glycyrrhizin high-concentration preparation
NO20055311L (no) Farmasoytisk aktive ornitinderivater, ammoniumsalter derav og fremgangsmater for fremstilling av det samme
WO2003095471A3 (en) Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation